title: Successful prolonged use of recombinant human insulin-like growth factor-1 in a child with cystic fibrosis.
abstract: Growth failure is a common and complicated process in children with cystic fibrosis (CF). Growth hormone, which is becoming a more commonly used agent in such patients, has demonstrated beneficial effects aside from increased growth velocity. Recently, insulin-like growth factor-1 has gained significant attention in the understanding of growth failure in children with CF. We report the successful prolonged use of recombinant human insulin-like growth factor-1 in an adolescent boy with CF, who demonstrated significant clinical benefits from the therapy.
authors: Division of Pulmonary Medicine, Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA. mhaupt@childrensmemorial.org
authors: Mark E
authors: ME
authors: Haupt
authors: Ellen E
authors: EE
authors: Kim
authors: Adrienne L
authors: AL
authors: Prestridge